- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Marc Boutin Discusses Improving Quality While Reducing Costs
Aligning the care delivered with the patient's own desires is the biggest opportunity available to drive costs down while improving quality, according to Marc Boutin, JD, chief executive officer of the National Health Council.
Balancing the need to improve quality while simultaneously driving cost down has been a challenge in US healthcare for decades, and the biggest opportunity to make some progress is through focusing care on the patient's desire, said Marc Boutin, JD, chief executive officer of the National Health Council, at the Pharmacy Quality Alliance's 10th Annual Meeting in Arlington, Virginia.
"If you align the care that is provided to the patient, it helps them achieve their goals, their aspirations, and it allows you to eliminate the care that they don't want," he said.
Impact of Amivantamab-Lazertinib on EGFR, MET Resistance Alterations in NSCLC: Danny Nguyen, MD
September 15th 2025The combination of amivantamab and lazertinib in first-line non–small cell lung cancer (NSCLC) significantly reduces resistance mechanisms with implications for second-line treatment, said Danny Nguyen, MD, of City of Hope.
Read More
Disparities in Biomarker Testing Impact Nonsquamous NSCLC Outcomes: Surbhi Singhal, MD
September 6th 2025Surbhi Singhal, MD, of the University of California Davis, discussed disparities in biomarker testing among patients diagnosed with stage IV nonsquamous non–small cell lung cancer (NSCLC).
Read More
